The American Academy of Dermatology released a position statement on automatic substitution that calls for several thresholds to all be met before a biosimilar can be substituted. Read the statement here.
![Background Image](https://safebiologics.org/wp-content/themes/safebiologics/assets/images/default-page-bg.jpg)
The American Academy of Dermatology released a position statement on automatic substitution that calls for several thresholds to all be met before a biosimilar can be substituted. Read the statement here.